Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 61

recruiting
3 982
countries
28
conditions
2 106

2 729 trials match your criteria

Study of Adagrasib Alone and with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Adagrasib

Title: Long-term treatment study of oral decitabine and cedazuridine combination for patients with AML, MDS, CMML, or solid tumors who previously received ASTX727

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Cedazuridine

Study on VE303 for Preventing Recurrent C. difficile Infection in Patients

Investigational
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Bacilli, Cluster Xvii, Strain Relative Clostridium_Aq Innocuum, Live

Study of Brigatinib for Children and Young Adults with ALK+ Anaplastic Large Cell Lymphoma, Inflammatory Myofibroblastic Tumors, or Other Solid Tumors

Registered drugNo placebo
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years
  • Substances:Brigatinib

SAPHO syndrome

Recruiting

Study on the Effectiveness and Safety of Etanercept for Patients with SAPHO Syndrome

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Etanercept

Cardiomyopathy

Recruiting

Study on Valsartan and Sacubitril for Preventing Disease Progression in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Sacubitril

Sarcopenia

Recruiting

Evaluation of nandrolone decanoate treatment combined with physiotherapy and diet in elderly patients with sarcopenia

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Nandrolone Decanoate

Study on Pancreatic Enzyme Replacement Therapy for Adults with Pancreatic Exocrine Insufficiency After Pancreatic Surgery

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Pancreas Powder

Study of Elenestinib for Patients with Indolent Systemic Mastocytosis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Elenestinib Phosphate

Study of Nivolumab and Chemotherapy Combination for Patients with Refractory Hodgkin's Lymphoma

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab

Study on Dimethyl Fumarate for Patients with Mild Cognitive Impairment and Alzheimer's Disease

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Dimethyl Fumarate
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.